These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34529108)

  • 41. Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting.
    Aristin Revilla S; Kranenburg O; Coffer PJ
    Front Immunol; 2022; 13():903564. PubMed ID: 35874729
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor-infiltrating lymphocyte: features and prognosis of lymphocytes infiltration on colorectal cancer.
    Qin M; Chen G; Hou J; Wang L; Wang Q; Wang L; Jiang D; Hu Y; Xie B; Chen J; Wei H; Xu G
    Bioengineered; 2022 Jun; 13(6):14872-14888. PubMed ID: 36633318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Prognostic Value of FoxP3+ Tumour-Infiltrating Lymphocytes in Rectal Cancer Depends on Immune Phenotypes Defined by CD8+ Cytotoxic T Cell Density.
    Schnellhardt S; Hirneth J; Büttner-Herold M; Daniel C; Haderlein M; Hartmann A; Fietkau R; Distel L
    Front Immunol; 2022; 13():781222. PubMed ID: 35140715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinicopathological characteristics of type 2 diabetes mellitus complicated with colorectal cancer].
    Han ZH; Chen JJ; Feng N; Niu PF; Song C; Gao ZY; Gao QK; Ji DB; Wang WB; Lei FM; Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Oct; 22(10):966-971. PubMed ID: 31630495
    [No Abstract]   [Full Text] [Related]  

  • 45. Immune cell concentrations among the primary tumor microenvironment in colorectal cancer patients predicted by clinicopathologic characteristics and blood indexes.
    Guo G; Wang Y; Zhou Y; Quan Q; Zhang Y; Wang H; Zhang B; Xia L
    J Immunother Cancer; 2019 Jul; 7(1):179. PubMed ID: 31300050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer.
    Narayanan S; Kawaguchi T; Yan L; Peng X; Qi Q; Takabe K
    Ann Surg Oncol; 2018 Aug; 25(8):2323-2331. PubMed ID: 29770915
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Accumulation of FoxP3+ T regulatory cells in the tumor microenvironment of human colorectal adenomas.
    Hua W; Yuan A; Zheng W; Li C; Cui J; Pang Z; Zhang L; Li Z; Goll R; Cui G
    Pathol Res Pract; 2016 Feb; 212(2):106-12. PubMed ID: 26724144
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival.
    Sorrentino C; D'Antonio L; Fieni C; Ciummo SL; Di Carlo E
    Front Immunol; 2021; 12():778329. PubMed ID: 34975867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical impact of heterogeneously distributed tumor-infiltrating lymphocytes on the prognosis of colorectal cancer.
    Liu L; Long M; Su S; Wang L; Liu J
    PeerJ; 2024; 12():e16747. PubMed ID: 38223758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low level of stromal lectin-like oxidized LDL receptor 1 and CD8
    Katayama C; Yokobori T; Ozawa N; Suga K; Shiraishi T; Okada T; Osone K; Katoh R; Suto T; Motegi Y; Ogawa H; Sano A; Sakai M; Sohda M; Erkhem-Ochir B; Gombodorj N; Katayama A; Oyama T; Shirabe K; Kuwano H; Saeki H
    Cancer Rep (Hoboken); 2021 Aug; 4(4):e1364. PubMed ID: 33675293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Alteration of T-Cell Heterogeneity and PD-L1 Colocalization During dMMR Colorectal Cancer Progression Defined by Multiplex Immunohistochemistry.
    Yan H; Li Y; Wang X; Qian J; Xu M; Peng J; Huang D
    Front Oncol; 2022; 12():867658. PubMed ID: 35669431
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancer.
    Chaput N; Svrcek M; Aupérin A; Locher C; Drusch F; Malka D; Taïeb J; Goéré D; Ducreux M; Boige V
    Br J Cancer; 2013 Aug; 109(4):1013-22. PubMed ID: 23868006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dendritic cell and macrophage infiltration in microsatellite-unstable and microsatellite-stable colorectal cancer.
    Bauer K; Michel S; Reuschenbach M; Nelius N; von Knebel Doeberitz M; Kloor M
    Fam Cancer; 2011 Sep; 10(3):557-65. PubMed ID: 21598004
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD206
    Heng Y; Zhu X; Lin H; Jingyu M; Ding X; Tao L; Lu L
    J Transl Med; 2023 Mar; 21(1):167. PubMed ID: 36864443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SIRT1 induces the accumulation of TAMs at colorectal cancer tumor sites via the CXCR4/CXCL12 axis.
    Fang H; Huang Y; Luo Y; Tang J; Yu M; Zhang Y; Zhong M
    Cell Immunol; 2022 Jan; 371():104458. PubMed ID: 34847407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features.
    Nazemalhosseini-Mojarad E; Mohammadpour S; Torshizi Esafahani A; Gharib E; Larki P; Moradi A; Amin Porhoseingholi M; Asadzade Aghdaei H; Kuppen PJK; Zali MR
    J Cell Physiol; 2019 Apr; 234(4):4768-4777. PubMed ID: 30370522
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Propolis Has an Anticancer Effect on Early Stage Colorectal Cancer by Affecting Epithelial Differentiation and Gut Immunity in the Tumor Microenvironment.
    Shen MH; Liu CY; Chang KW; Lai CL; Chang SC; Huang CJ
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960147
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Immune-Related Factors as Prognostic Markers for Resectable Colorectal Cancer].
    Tomochika S; Kuwahara T; Suzuki N; Hazama S; Nagano H
    Gan To Kagaku Ryoho; 2021 Mar; 48(3):325-330. PubMed ID: 33790150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Excessive HSP70/TLR2 activation leads to remodeling of the tumor immune microenvironment to resist chemotherapy sensitivity of mFOLFOX in colorectal cancer.
    Feng H; Guo Z; Chen X; Liu K; Li H; Jia W; Wang C; Luo F; Ji X; Zhang T; Zhao R; Cheng X
    Clin Immunol; 2022 Dec; 245():109157. PubMed ID: 36244673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.